Haymaker Acquisition Corp. III
Status: Deal Closed
U=S+W/4
W=S@11.5
| IPO Proceeds, $M | $317.50M |
|---|---|
| IPO Date | Mar 2, 2021 |
| CEO | Steven J. Heyer |
| Left Lead | Citigroup |
| IPO Cash in Trust | 100.0% |
| SPAC Tenor | 24 months |
| IPO Sector | Consumer |
| IPO Geography | US/Canada |
| Target Company | BioTE Holdings |
| Deal Announced | Dec 13, 2021 |
| Deal Size, $M | $667.00M |
| Deal Sector | Healthcare |
| Deal Geography | US/Canada |
| SEC Filings | www.sec.gov |
| Approval Vote | May 24, 2022 |
| Amendment Vote | TBD |
| Closing Date | May 26, 2022 |
Formerly HYAC
BTMD
BTMDW
| Price | $6.06 |
|---|---|
| Last closing price | $6.09 |
| H/L, today | $5.85 / $6.12 |
| H/L, 52-week | $2.75 / $8.22 |
| Volume, today | 127,888 |
| Volume, 3-month avg. | N/A |
Sign up for Free Trial
No credit card required
Sign in for more on Haymaker Acquisition Corp. III:
- Structure and cap table
- 7 directors & officers
- 23 filings and events
- 2 underwriters
- 9 deal advisors
- 3 legal advisors
Structure
Sign in to view structure, cap table, and calendar of events.
Team
| Name | Age | Title |
|---|---|---|
| Steven J. Heyer | 68 | Chief Executive Officer and Director |
| Andrew R. Heyer | 63 | President and Director |
| Christopher Bradley | 43 | Chief Financial Officer and Secretary |
| Joseph M. Tonnos | 33 | Senior Vice President |
| Roger Meltzer | 69 | Director |
| Frederic H. Mayerson | 74 | Director |
| Stephen W. Powell | 62 | Director |
Sign in to view team biographies and more sponsor and affiliate data.
Advisors
Underwriters
| Citigroup | Joint BR | 18,000,000 | units |
| Cantor Fitzgerald | Joint BR | 12,000,000 | |
| 30,000,000 | units | ||
| Up-Front UW fee | 2.00 | % | |
| Deferred UW fee |
3.50 | % |
Sign in to view more advisor data.
Deal
Sign in to view merger details and deal financials.